Díte P, Ruzicka M, Zboril V, Novotný I
Dept. of Medicine and Gastroenterology, University Hospital, Brno, Czech Republic.
Endoscopy. 2003 Jul;35(7):553-8. doi: 10.1055/s-2003-40237.
Invasive treatment for abdominal pain due to chronic pancreatitis may be either surgical or endoscopic, particularly in cases of ductal obstruction. To date, the data published on the effectiveness of these two forms of therapy have been mostly retrospective, and there have been no randomized studies. A prospective, randomized study comparing surgery with endoscopy in patients with painful obstructive chronic pancreatitis was therefore conducted.
Consecutive patients with pancreatic duct obstruction and pain were invited to participate in a randomized trial comparing endotherapy and surgery, the latter consisting of resection and drainage procedures, depending on the patient's individual situation. Patients who did not agree to participation and randomization were also further assessed using the same follow-up protocol.
Of 140 eligible patients, only 72 agreed to be randomized. Surgery consisted of resection (80 %) and drainage (20 %) procedures, while endotherapy included sphincterotomy and stenting (52 %) and/or stone removal (23 %). In the entire group, the initial success rates were similar for both groups, but at the 5-year follow-up, complete absence of pain was more frequent after surgery (37 % vs. 14 %), with the rate of partial relief being similar (49 % vs. 51 %). In the randomized subgroup, results were similar (pain absence 34 % after surgery vs. 15 % after endotherapy, relief 52 % after surgery vs. 46 % after endotherapy). The increase in body weight was also greater by 20 - 25 % in the surgical group, while new-onset diabetes developed with similar frequency in both groups (34 - 43 %), again with no differences between the results for the whole group and the randomized subgroup.
Surgery is superior to endotherapy for long-term pain reduction in patients with painful obstructive chronic pancreatitis. Better selection of patients for endotherapy may be helpful in order to maximize results. Due to its low degree of invasiveness, however, endotherapy can be offered as a first-line treatment, with surgery being performed in case of failure and/or recurrence.
慢性胰腺炎所致腹痛的侵入性治疗方式可以是手术治疗或内镜治疗,尤其是在导管阻塞的病例中。迄今为止,关于这两种治疗方式有效性的已发表数据大多为回顾性的,且尚无随机研究。因此,开展了一项前瞻性随机研究,比较手术治疗与内镜治疗对疼痛性梗阻性慢性胰腺炎患者的疗效。
连续纳入患有胰管梗阻和疼痛的患者,邀请他们参与一项比较内镜治疗和手术治疗的随机试验,手术治疗根据患者个体情况包括切除和引流手术。不同意参与随机分组的患者也采用相同的随访方案进行进一步评估。
140例符合条件的患者中,只有72例同意随机分组。手术治疗包括切除手术(80%)和引流手术(20%),而内镜治疗包括括约肌切开术和支架置入术(52%)和/或结石清除术(23%)。在整个研究组中,两组的初始成功率相似,但在5年随访时,手术治疗后完全无痛更为常见(37% 对14%),部分缓解率相似(49% 对51%)。在随机分组的亚组中,结果相似(手术治疗后无痛率为34%,内镜治疗后为15%;手术治疗后缓解率为52%,内镜治疗后为46%)。手术组体重增加也多20% - 25%,而两组新发糖尿病的发生率相似(34% - 43%),整个研究组和随机分组亚组的结果同样无差异。
对于疼痛性梗阻性慢性胰腺炎患者,手术治疗在长期减轻疼痛方面优于内镜治疗。更好地选择适合内镜治疗的患者可能有助于使治疗效果最大化。然而,由于内镜治疗侵入性程度低,可以作为一线治疗方法,若治疗失败和/或复发则进行手术治疗。